(0)

Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

‹
›
​

Join us in Washington, DC
June 15-19, 2025

Join us at the DIA 2025 Global Annual Meeting—the ultimate hub for industry visionaries, regulators, government leaders, academics, innovators, and patients. Set in the dynamic city of Washington DC, this premier event invites global stakeholders to unite, collaborate, and ignite transformation in the life sciences.

Register Now​

Pre-Sale Sold Out!

DIA 2025

Pre-sale tickets for DIA 2025 have sold out, but you can still take advantage of early registration pricing until February 13th. Join global colleagues, peers and leading industry, academic and regulatory experts in a multi-disciplinary, neutral setting to tackle challenges and drive impact in medical product development.

Join Us Today!

Announcements and Highlights

DIA 2025

Join the Conversation!

Customer Testimonials

"The DIA meeting is so incredibly valuable from a professional standpoint for the networking, the content…its really super valuable, it's a must-attend meeting."

— Jennifer Emerson, Head of Quality Analytics and Risk Management, Boehringler-Ingleheim

"The way that DIA's Global Annual Meeting is different from other industry events is that it offers something for everyone. It’s the most democratic congress or association to which I belong, there are colleagues from every aspect of bio-pharmaceutical product development, and you learn a lot and it's just a lot of fun."

— Meg Richards, Executive Director, Strategy, Penalgo

"I love the Global Annual Meeting because it does bring together different disciplines, different experts from industry, from academia, from regulators to address the topics at hand and to bring that and make that available to attendees. "

— Jeremy Jokinen, Vice President and Head of Safety Evidence and Science, BMS

Program Committee

  • Linda Akunne, MPH
    Linda Akunne, MPH • Chief, Project Management Staff, ORO, OND, CDER
    FDA, United States
  • Venkatraman Balasubramanian, PhD, MBA
    Venkatraman Balasubramanian, PhD, MBA • Healthcare and Life Sciences Strategic Advisor
    VB Insights, LLC, United States
  • Greg Ball, PhD
    Greg Ball, PhD • Safety Data Scientist
    ASAPprocess, United States
  • Amy Bertha
    Amy Bertha • Executive Director, Regulatory Policy and Science
    Bayer, United States
  • Sanghita Bhattacharya, PhD
    Sanghita Bhattacharya, PhD • Director Data Science , Feasibility and Analytics, Clinical Operations
    Johnson & Johnson Innovative Medicine, United States
  • Asia Blackwell
    Asia Blackwell • Consumer Safety Officer
    FDA, United States
  • Claire Blanchette, PMP
    Claire Blanchette, PMP • Executive Drug Development Program Leader
    Consultant, United States
  • Tywnia Brewton
    Tywnia Brewton • Executive Director, Human Resources
    Astellas , United States
  • James Buchanan, PharmD
    James Buchanan, PharmD • President
    Covilance LLC, United States
  • Mandy Kaur Budwal-Jagait, MSc
    Mandy Kaur Budwal-Jagait, MSc • Head of GCP and Lead Senior GCP Inspector
    Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom
  • Meghana Chalasani, MHA
    Meghana Chalasani, MHA • Associate Director for Clinical Trial Innovation, Office of New Drugs, CDER
    FDA, United States
  • Joan Chambers
    Joan Chambers • Senior Consultant
    Tufts CSDD, United States
  • Rachel Chasse, MS
    Rachel Chasse, MS • Associate Director, Digital Science Strategy
    AbbVie, United States
  • Christine Colvis, PhD
    Christine Colvis, PhD • Director, Drug Development Partnership Programs
    National Center for Advancing Translational Sciences (NCATS), United States
  • Karen Correa, PhD
    Karen Correa, PhD • Vice President, Head of Global Clinical Operations
    Takeda, United States
  • Solange Corriol-Rohou, DrMed, MD, PhD
    Solange Corriol-Rohou, DrMed, MD, PhD • Senior Director, Global Regulatory Affairs & Policy, R&D, Europe
    AstraZeneca , France
  • Stephanie Y. Crawford, PhD, MPH, MS
    Stephanie Y. Crawford, PhD, MPH, MS • Professor, Pharmacy Systems, Outcomes and Policy
    University of Illinois at Chicago, United States
  • Alysha Croker, PhD
    Alysha Croker, PhD • Director, Centre for Policy, Pediatrics and International Collaboration, BRDD
    Health Canada, Canada
  • Victoria DiBiaso, BSN, MPH, RN
    Victoria DiBiaso, BSN, MPH, RN • Global Head, Patient Informed Development and Health Value Translation
    Sanofi, France
  • Megan Doyle, JD, MPH
    Megan Doyle, JD, MPH • Associate Vice President, Assistant General Counsel - Diagnostics
    Eli Lilly & Company, United States
  • Nancy A Dreyer, PhD, MPH, FISPE
    Nancy A Dreyer, PhD, MPH, FISPE • Founder
    Dreyer Strategies LLC, United States
  • Joseph Dustin
    Joseph Dustin • Founder and Managing Partner
    eClinical Consulting, United States
  • Jennifer Emerson, PhD, MPH, RN, PMP
    Jennifer Emerson, PhD, MPH, RN, PMP • Head Quality Analytics & Risk Management
    Boehringer Ingelheim, Germany
  • Andrew Emmett, MPH
    Andrew Emmett, MPH • FDA Liaison | US Regulatory Policy and Global Intelligence
    Pfizer Inc, United States
  • Ron Fitzmartin, PhD, MBA
    Ron Fitzmartin, PhD, MBA • Senior Advisor, Office of Regulatory Operations, CBER
    FDA, United States
  • Celeste Frankenfeld Lamm, PhD
    Celeste Frankenfeld Lamm, PhD • Senior Director, Global Regulatory Affairs – CMC
    Merck Sharp & Dohme LLC , United States
  • Danielle Friend Economo, PhD
    Danielle Friend Economo, PhD • Senior Director, US Head Regulatory Policy and Intelligence
    Johnson & Johnson Innovative Medicine, United States
  • David Fryrear, MS
    David Fryrear, MS • Executive Vice President and Head of Quality Assurance
    Astellas, United States
  • Cheryl Grandinetti, PharmD
    Cheryl Grandinetti, PharmD • Associate Director for Clinical Policy, CDER/OC/OSI/DCCE
    FDA, United States
  • Courtney Granville, PhD, MPH
    Courtney Granville, PhD, MPH • Chief Scientific Officer
    GO2 For Lung Cancer, United States
  • Lani Hashimoto
    Lani Hashimoto • Associate Director, Patient Engagement
    Novartis Pharmaceuticals Corporation, United States
  • Sabine Haubenreisser, PhD, MSc
    Sabine Haubenreisser, PhD, MSc • Principal Scientific Administrator, Stakeholders and Communication Division
    European Medicines Agency, Netherlands
  • Cammilla Horta Gomes, MA, MPharm
    Cammilla Horta Gomes, MA, MPharm • Latam Regulatory Policy Lead
    Roche, Brazil
  • Stacy Hurt, MBA, MHA
    Stacy Hurt, MBA, MHA • Chief Patient Officer
    Parexel , United States
  • Huong Huynh, PhD
    Huong Huynh, PhD • Director of Regulatory Science
    Critical Path Institute, United States
  • Emily (Xianghong) Jing, PhD
    Emily (Xianghong) Jing, PhD • Associate Director for Scientific Coordination, OBP, OPQ, CDER
    FDA, United States
  • Jeremy Jokinen, PhD, MS
    Jeremy Jokinen, PhD, MS • Vice President and Head, Safety Evidence and Sciences
    Bristol-Myers Squibb Company, United States
  • Dominique Lagrave, PharmD
    Dominique Lagrave, PharmD • Senior Vice President of Regulatory Innovation
    Accumulus Synergy, United States
  • Cathryn C Lee, MSN
    Cathryn C Lee, MSN • Director, Office of Program Operations, PDIMS, OND, CDER
    FDA, United States
  • Jingyu (Julia) Luan, PhD
    Jingyu (Julia) Luan, PhD • Executive Regulatory Science Director, BioPharmaceuticals R&D
    AstraZeneca, United States
  • Demetra Macheras, MBA
    Demetra Macheras, MBA • Director, Regulatory Policy and Intelligence - Regulatory Affairs
    AbbVie, United States
  • Nicole Mahoney, PhD
    Nicole Mahoney, PhD • Executive Director US Regulatory Policy & Intelligence
    Novartis Pharmaceuticals Corporation, United States
  • Lindsay McNair, MD, MPH, MS
    Lindsay McNair, MD, MPH, MS • Principal Consultant
    Equipoise Consulting, United States
  • Melodi J McNeil, MS, RPh
    Melodi J McNeil, MS, RPh • Director, Regulatory Policy and Intelligence
    AbbVie, United States
  • David Meats
    David Meats • Director, Regulatory Services Management
    Certara, United States
  • Timothe Menard, PharmD, MSc
    Timothe Menard, PharmD, MSc • Global Head, Quality Excellence Digital | Bioethics Coach (Data Ethics)
    F. Hoffmann-La Roche Ltd, Switzerland
  • Pallavi Mishra-Kalyani, PhD, MS
    Pallavi Mishra-Kalyani, PhD, MS • Deputy Division Director, DBV, OB, CDER
    FDA, United States
  • May F Mo, MBA, MS
    May F Mo, MBA, MS • Executive Director, Biostatistics
    Amgen, United States
  • Monica Munoz, PharmD, PhD
    Monica Munoz, PharmD, PhD • Division Director, Division of Pharmacovigilance-I, OSE, CDER
    FDA, United States
  • Lauren Oliva, PharmD, RPh
    Lauren Oliva, PharmD, RPh • US Lead, Global Regulatory Policy
    Biogen, United States
  • Y. Veronica Pei, MD, MEd, MPH
    Y. Veronica Pei, MD, MEd, MPH • Acting Associate Director, Biomedical Informatics and Regulatory Review Science
    FDA, United States
  • Vada A. Perkins, DrSc, MSc
    Vada A. Perkins, DrSc, MSc • Vice President, Global Head of Regulatory Intelligence & Policy
    Boehringer Ingelheim, United States
  • Ranjini Prithviraj, PhD, PMP
    Ranjini Prithviraj, PhD, PMP • Director, Global Medical Affairs, Publication Management
    Regeneron, United States
  • Kim Ribeiro, MS
    Kim Ribeiro, MS •
    United States
  • Margaret Richards, PhD, MPH
    Margaret Richards, PhD, MPH • Executive Director, Solutions
    Panalgo, United States
  • Elizabeth Rosenkrands-Lange, MPH, MS
    Elizabeth Rosenkrands-Lange, MPH, MS • Senior Director/ Head of US Regulatory Scientific Policy
    EMD Serono, Part of Merck KGaA, Darmstadt, Germany, United States
  • Cynthia Rothblum-Oviatt
    Cynthia Rothblum-Oviatt • Science Policy Analyst, Rare Disease Team, OND, CDER
    FDA, United States
  • Leslie Sam
    Leslie Sam • President
    Leslie Sam and Associates, LLC, United States
  • Earl Seltzer, MBA
    Earl Seltzer, MBA • Senior Director, Partnerships and Innovation
    CTI, United States
  • Anjali Shah, PharmD
    Anjali Shah, PharmD • Executive Director, Business Capabilities and Innovation, WWPS
    Bristol-Myers Squibb Company, United States
  • Nancy Pire Smerkanich, DrSc, MS
    Nancy Pire Smerkanich, DrSc, MS • Assistant Professor Regulatory & Quality Sciences
    University of Southern California School of Pharmacy, United States
  • Elizabeth Somers, MS
    Elizabeth Somers, MS • Executive Director, Global Project and Alliance Management
    Merck Sharp & Dohme LLC, United States
  • Benjamin Stevens, PhD, MPH
    Benjamin Stevens, PhD, MPH • Director CMC Policy and Advocacy
    GlaxoSmithKline, United States
  • Nancy Linda Styple
    Nancy Linda Styple • Project Management Leader
    Bayer AG, United States
  • Ling Su, PhD
    Ling Su, PhD • Research Fellow
    Shenyang Pharmaceutical University, Yeehong Business School, China
  • Alec Thompson, PharmD, MS
    Alec Thompson, PharmD, MS • Senior Product Manager, Oncology
    Gilead Sciences, United States
  • Michael Torok, PhD
    Michael Torok, PhD • Vice President, Global Head of Quality Assurance Programs
    Genentech, A Member of the Roche Group, United States
  • Phil Tregunno
    Phil Tregunno • Deputy Director - Patient Safety Monitoring
    Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom
  • Yoshiaki Uyama, PhD, RPh
    Yoshiaki Uyama, PhD, RPh • Associate Executive Director
    Pharmaceuticals and Medical Devices Agency (PMDA), Japan
  • James Valentine, JD, MHS
    James Valentine, JD, MHS • Director
    Hyman, Phelps & McNamara, PC, United States
  • James Wabby, MHS
    James Wabby, MHS • Global Head, Regulatory Affairs, Emerging Technologies and Combination Products
    AbbVie, United States
  • Paula Walker, MA
    Paula Walker, MA • Global Head of Risk Based Quality Management
    Roche Products Ltd., United Kingdom
  • Robin Whitsell
    Robin Whitsell • President
    Whitsell Innovations, Inc., United States
  • Amira Younes
    Amira Younes • Director, Global Regulatory Policy EEMEA
    MSD, United Arab Emirates
Load More

Stay Connected!

Sign up for our newsletter to get the latest updates, exclusive insights, and special offers delivered straight to your inbox. Be the first to know about upcoming events, new releases, and more. Join our community today!

DIA 2025
Join Our List

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.